Research
Can aspirin reduce the risk of hepatocellular carcinoma in subjects with cirrhosis: a multicentre, placebo-controlled clinical trial; NHMRC Clinical Trails and Cohort Studies Grant-APP 2041836; $5,115,622.70; 2025-2029; Curtin University and Murdoch University.
by Khurshid Alam
College of Business